Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-10
DOI
10.3389/fimmu.2020.02021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
- (2020) Michael D Hill et al. LANCET
- Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
- (2020) Jeremy Chataway et al. LANCET NEUROLOGY
- Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia
- (2020) Anca Motataianu et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for neuroprotective therapy
- (2020) Yanming Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pioglitazone activates paraoxonase-2 in the brain: A novel neuroprotective mechanism
- (2020) Jennifer K. Blackburn et al. EXPERIMENTAL NEUROLOGY
- Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy
- (2020) Ali M. Alawieh et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
- (2020) Masayuki Tahara et al. LANCET NEUROLOGY
- The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease
- (2019) Birgit Liss et al. Annual Review of Pharmacology and Toxicology
- Aggregation of the nucleic acid–binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation
- (2019) Youjun Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis
- (2019) Carolina G Nicoletti et al. Multiple Sclerosis Journal
- Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
- (2019) Benjamin Turner et al. JOURNAL OF NEUROLOGY
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Safety and feasibility of minocycline in treatment of acute traumatic brain injury
- (2019) Jay Meythaler et al. BRAIN INJURY
- CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date
- (2019) Mihai Ancau et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Development and characterisation of novel anti‐C5 monoclonal antibodies capable of inhibiting complement in multiple species
- (2019) Wioleta M. Zelek et al. IMMUNOLOGY
- DHA protects PC12 cells against oxidative stress and apoptotic signals through the activation of the NFE2L2/HO-1 axis
- (2019) Maria Clementi et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?
- (2019) Lisa B. Grech et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Magnesium sulfate protects blood–brain barrier integrity and reduces brain edema after acute ischemic stroke in rats
- (2019) Javad Shadman et al. METABOLIC BRAIN DISEASE
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous Magnesium Sulfate in Acute Stroke
- (2019) Konstantinos I. Avgerinos et al. STROKE
- Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015
- (2019) Jaime Raymond et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder
- (2019) Maureen A. Mealy et al. MEDICINE
- Revisiting the role of the innate immune complement system in ALS
- (2019) Sandra E. Parker et al. NEUROBIOLOGY OF DISEASE
- The association between antihypertensive therapy and the incidence of Parkinson’s disease in patients followed in general practices in Germany
- (2019) Ahmed Warda et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Copenhagen Head Injury Ciclosporin (CHIC) Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients
- (2019) Jesper Kelsen et al. JOURNAL OF NEUROTRAUMA
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- Docosahexaenoic acid decreased neuroinflammation in rat pups after controlled cortical impact
- (2019) Michelle E. Schober et al. EXPERIMENTAL NEUROLOGY
- Selegiline: a molecule with innovative potential
- (2019) Tamás Tábi et al. JOURNAL OF NEURAL TRANSMISSION
- Compendium of current complement therapeutics
- (2019) Wioleta M Zelek et al. MOLECULAR IMMUNOLOGY
- Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection
- (2019) Steven A. Robicsek et al. MOLECULAR NEUROBIOLOGY
- Complement dysregulation in the central nervous system during development and disease
- (2019) John D. Lee et al. SEMINARS IN IMMUNOLOGY
- Neuroprotection in Parkinson’s disease: facts and hopes
- (2019) András Salamon et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
- (2019) Yoo Jin Jung et al. Frontiers in Cell and Developmental Biology
- Discovery and development of NA-1 for the treatment of acute ischemic stroke
- (2018) Beatrice Ballarin et al. ACTA PHARMACOLOGICA SINICA
- The Evolving Understanding of Dopamine Neurons in the Substantia Nigra and Ventral Tegmental Area
- (2018) Stephanie C. Gantz et al. Annual Review of Physiology
- Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
- (2018) Caroline Moreau et al. ANTIOXIDANTS & REDOX SIGNALING
- Memantine improves outcomes after repetitive traumatic brain injury
- (2018) Zhengrong Mei et al. BEHAVIOURAL BRAIN RESEARCH
- Update in therapeutic strategies for Parkinsonʼs disease
- (2018) Jaime Kulisevsky et al. CURRENT OPINION IN NEUROLOGY
- Ublituximab for the treatment of CD20 positive B-cell malignancies
- (2018) Hani M. Babiker et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Inflammation in CNS neurodegenerative diseases
- (2018) Jodie Stephenson et al. IMMUNOLOGY
- How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
- (2018) Kazutoshi Watanabe et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Unveiling anti-oxidative and anti-inflammatory effects of docosahexaenoic acid and its lipid peroxidation product on lipopolysaccharide-stimulated BV-2 microglial cells
- (2018) Bo Yang et al. Journal of Neuroinflammation
- Identifying the role of complement in triggering neuroinflammation after traumatic brain injury
- (2018) Ali Alawieh et al. JOURNAL OF NEUROSCIENCE
- New tricks for an ancient system: Physiological and pathological roles of complement in the CNS
- (2018) Andrea J. Tenner et al. MOLECULAR IMMUNOLOGY
- Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis
- (2018) Anne-Lene Kjældgaard et al. MOLECULAR IMMUNOLOGY
- Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology
- (2018) Romina María Uranga et al. Oxidative Medicine and Cellular Longevity
- Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice
- (2018) Ali Alawieh et al. Science Translational Medicine
- Global Burden of Stroke
- (2018) Mira Katan et al. SEMINARS IN NEUROLOGY
- Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial
- (2018) Ji Man Hong et al. Trials
- The Effects of Memantine on Glutamic Receptor–Associated Nitrosative Stress in a Traumatic Brain Injury Rat Model
- (2018) Che-Chuan Wang et al. World Neurosurgery
- Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke
- (2018) Babak B. Navi et al. JAMA Neurology
- Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
- (2018) Joseph Jankovic et al. JAMA Neurology
- NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
- (2018) Brigitte Vanle et al. Translational Psychiatry
- Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway
- (2018) Liyan Hou et al. Redox Biology
- Current advances in ischemic stroke research and therapies
- (2018) Derek Barthels et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mitochondrial permeability transition pore: a potential drug target for neurodegeneration
- (2018) Komal Kalani et al. DRUG DISCOVERY TODAY
- Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients
- (2018) Rami Fakih et al. JOURNAL OF NEUROLOGY
- Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China
- (2018) Qiao Huang et al. Frontiers in Immunology
- Multiple sclerosis - a review
- (2018) R. Dobson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Lifetime prevalence of traumatic brain injury with loss of consciousness
- (2017) John D Corrigan et al. INJURY PREVENTION
- Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke
- (2017) Justin F Fraser et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis
- (2017) Simona Lattanzi et al. JOURNAL OF NEUROLOGY
- Phase II Clinical Trial of Atorvastatin in Mild Traumatic Brain Injury
- (2017) Claudia S. Robertson et al. JOURNAL OF NEUROTRAUMA
- Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Enrico Bertini et al. LANCET NEUROLOGY
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- (2017) James F Howard et al. LANCET NEUROLOGY
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Effects of DHA on Hippocampal Autophagy and Lysosome Function After Traumatic Brain Injury
- (2017) Yan Yin et al. MOLECULAR NEUROBIOLOGY
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Selective neuronal vulnerability in Parkinson disease
- (2017) D. James Surmeier et al. NATURE REVIEWS NEUROSCIENCE
- Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
- (2017) Luanne M. Metz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: A randomized, placebo-controlled trial
- (2017) Hiroko Noguchi et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Transformation of Astrocytes to a Neuroprotective Phenotype by Microglia via P2Y 1 Receptor Downregulation
- (2017) Youichi Shinozaki et al. Cell Reports
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study
- (2017) Robert A. Hauser et al. Journal of Parkinsons Disease
- The MPTP Story
- (2017) J. William Langston Journal of Parkinsons Disease
- A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)
- (2017) Kevin M. Biglan et al. Annals of Clinical and Translational Neurology
- Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
- (2017) Antonio Martin-Bastida et al. Scientific Reports
- A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine/D-serine
- (2017) Hongqiu Guo et al. Scientific Reports
- Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease
- (2016) Chava Peretz et al. CLINICAL NEUROPHARMACOLOGY
- Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study
- (2016) P. S. Sørensen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- Complement activation at the motor end-plates in amyotrophic lateral sclerosis
- (2016) Nawal Bahia El Idrissi et al. Journal of Neuroinflammation
- Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials
- (2016) Julio J. Secades et al. Journal of Stroke & Cerebrovascular Diseases
- Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
- (2016) Laure Peyro Saint Paul et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football
- (2016) JONATHAN M. OLIVER et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway
- (2016) Mei Zhang et al. Neurocritical Care
- Clinically Isolated Syndromes: Clinical Characteristics, Differential Diagnosis, and Management
- (2016) Husnu Efendi Noropsikiyatri Arsivi-Archives of Neuropsychiatry
- Complement and microglia mediate early synapse loss in Alzheimer mouse models
- (2016) S. Hong et al. SCIENCE
- Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions
- (2016) Faith H. Brennan et al. SEMINARS IN IMMUNOLOGY
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials
- (2016) Julio J. Secades et al. Journal of Stroke & Cerebrovascular Diseases
- Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies
- (2016) Francisco J. Carvajal et al. NEURAL PLASTICITY
- Emerging Roles for the Immune System in Traumatic Brain Injury
- (2016) Celia A. McKee et al. Frontiers in Immunology
- Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
- (2016) Ding Chen et al. Journal of Clinical Medicine
- A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?
- (2015) R. Sheelakumari et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus
- (2015) Iliana Michailidou et al. ANNALS OF NEUROLOGY
- Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons
- (2015) Consiglia Pacelli et al. CURRENT BIOLOGY
- α-Synuclein and Lewy pathology in Parkinsonʼs disease
- (2015) Lorraine V. Kalia et al. CURRENT OPINION IN NEUROLOGY
- Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
- (2015) A. E. Elia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy
- (2015) Andrii Domanskyi et al. HUMAN GENE THERAPY
- The brain cytokine levels are modulated by estrogen following traumatic brain injury: Which estrogen receptor serves as modulator?
- (2015) Mohammad Khaksari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Coenzyme Q10 Protects Astrocytes from ROS-Induced Damage through Inhibition of Mitochondria-Mediated Cell Death Pathway
- (2015) Li Jing et al. International Journal of Biological Sciences
- Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
- (2015) Jesus Lovera et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Targeting voltage-gated calcium channels in neurological and psychiatric diseases
- (2015) Gerald W. Zamponi NATURE REVIEWS DRUG DISCOVERY
- Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke
- (2015) Jeffrey L. Saver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis
- (2015) Yakun Lang et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Neuroprotection for ischaemic stroke: Current status and challenges
- (2015) Antonio Moretti et al. PHARMACOLOGY & THERAPEUTICS
- An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice
- (2015) Marieta M. Ruseva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use
- (2015) Eva Havrdova et al. Therapeutic Advances in Neurological Disorders
- Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
- (2015) Roberto Bomprezzi Therapeutic Advances in Neurological Disorders
- Complement System Part II: Role in Immunity
- (2015) Nicolas S. Merle et al. Frontiers in Immunology
- Complement in the Homeostatic and Ischemic Brain
- (2015) Ali Alawieh et al. Frontiers in Immunology
- Time-Dependent Protection of CB2 Receptor Agonist in Stroke
- (2015) Seong-Jin Yu et al. PLoS One
- Clinical Trials in Acute Ischemic Stroke
- (2014) Kiyoshi Kikuchi et al. CNS DRUGS
- A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis
- (2014) T. Lenglet et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis
- (2014) T. M. Woodruff et al. JOURNAL OF IMMUNOLOGY
- Inhibition of the Membrane Attack Complex of the Complement System Reduces Secondary Neuroaxonal Loss and Promotes Neurologic Recovery after Traumatic Brain Injury in Mice
- (2014) K. Fluiter et al. JOURNAL OF IMMUNOLOGY
- Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood
- (2014) S. Mantovani et al. JOURNAL OF NEUROIMMUNOLOGY
- Docosahexaenoic Acid Reduces ER Stress and Abnormal Protein Accumulation and Improves Neuronal Function Following Traumatic Brain Injury
- (2014) G. Begum et al. JOURNAL OF NEUROSCIENCE
- Neurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
- (2014) L.-G. Bodea et al. JOURNAL OF NEUROSCIENCE
- The Effects of Citicoline on Acute Ischemic Stroke: A Review
- (2014) Karsten Overgaard Journal of Stroke & Cerebrovascular Diseases
- The role of iron in brain ageing and neurodegenerative disorders
- (2014) Roberta J Ward et al. LANCET NEUROLOGY
- Neuroprotection by Docosahexaenoic Acid in Brain Injury
- (2014) Hee-Yong Kim MILITARY MEDICINE
- Very Early Administration of Progesterone for Acute Traumatic Brain Injury
- (2014) David W. Wright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Therapeutic Benefit of C1-Esterase Inhibitor in Neuromyelitis Optica Evaluated In Vitro and in an Experimental Rat Model
- (2014) Lukmanee Tradtrantip et al. PLoS One
- Citicoline in addictive disorders: a review of the literature
- (2014) Nicholas D. Wignall et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
- (2014) So-Young Huh et al. JAMA Neurology
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
- (2013) David Devos et al. ANTIOXIDANTS & REDOX SIGNALING
- Attenuated effects of Neu2000 on hypoxia-induced synaptic activities in a rat hippocampus
- (2013) Jihyun Noh et al. ARCHIVES OF PHARMACAL RESEARCH
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status
- (2013) Yuewei Sheng et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
- (2013) Giulia Ambrosi et al. JOURNAL OF NEURAL TRANSMISSION
- Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke
- (2013) Olivia Hurtado et al. JOURNAL OF NEUROCHEMISTRY
- Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole
- (2013) Mark C. Bellingham JOURNAL OF NEUROPHYSIOLOGY
- 17β-Estradiol Confers Protection after Traumatic Brain Injury in the Rat and Involves Activation of G Protein-Coupled Estrogen Receptor 1
- (2013) Nicole L. Day et al. JOURNAL OF NEUROTRAUMA
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE
- (2013) Xianzhen Hu et al. MOLECULAR IMMUNOLOGY
- Role of magnesium sulfate in neuroprotection in acute ischemic stroke
- (2012) Harpreet Singh et al. Annals of Indian Academy of Neurology
- Glutathione and glutathione analogues; Therapeutic potentials
- (2012) Jian Hui Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Alpha 1 Anti-Trypsin: One Protein, Many Functions
- (2012) J. M. Hunt et al. CURRENT MOLECULAR MEDICINE
- Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
- (2012) Petra Dunkel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice
- (2012) Jiwon Yang et al. JOURNAL OF NEUROCHEMISTRY
- Complement activation in the injured central nervous system: another dual-edged sword?
- (2012) Faith H Brennan et al. Journal of Neuroinflammation
- Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS
- (2012) Laura J. Balcer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Living on the edge with too many mouths to feed: Why dopamine neurons die
- (2012) J. Paul Bolam et al. MOVEMENT DISORDERS
- Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients
- (2012) M Mäurer et al. Multiple Sclerosis Journal
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- A Pilot Study of Darbepoetin Alfa for Prophylactic Neuroprotection in Aortic Surgery
- (2012) Steven R. Messé et al. Neurocritical Care
- A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis
- (2012) Beatriz Pozuelo-Moyano et al. NEUROEPIDEMIOLOGY
- Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations
- (2012) Maxim V. Nikolaev et al. NEUROPHARMACOLOGY
- Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model
- (2012) C. Sunyach et al. NEUROPHARMACOLOGY
- Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE
- (2012) Xianzhen Hu et al. NEUROSCIENCE LETTERS
- Treatment of Acute Relapses in Multiple Sclerosis
- (2012) Regina Berkovich Neurotherapeutics
- Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology
- (2012) Justin Y. Kwan et al. PLoS One
- Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
- (2012) William M. Johnson et al. Nutrients
- Acute Minocycline Treatment Mitigates the Symptoms of Mild Blast-Induced Traumatic Brain Injury
- (2012) Erzsebet Kovesdi et al. Frontiers in Neurology
- Rare variants in the CYP27B1 gene are associated with multiple sclerosis
- (2011) Sreeram V. Ramagopalan et al. ANNALS OF NEUROLOGY
- The Anti-Inflammatory Effects of Dimethyl Fumarate in Astrocytes Involve Glutathione and Haem Oxygenase-1
- (2011) Shao Xia Lin et al. ASN Neuro
- Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats
- (2011) Jon Dang et al. BRAIN BEHAVIOR AND IMMUNITY
- The prospects of minocycline in multiple sclerosis
- (2011) Xiaohong Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease
- (2011) Candan Depboylu et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Improving reperfusion therapy for acute ischaemic stroke
- (2011) J. L. SAVER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
- (2011) Katja Herges et al. PLoS One
- Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States
- (2011) Opeolu Adeoye et al. STROKE
- Oxidation of Z α1-Antitrypsin by Cigarette Smoke Induces Polymerization
- (2010) Sam Alam et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla
- (2010) M. Inglese et al. BRAIN
- The complement system
- (2010) J. Vidya Sarma et al. CELL AND TISSUE RESEARCH
- Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke
- (2010) S.J. Cho et al. DRUG NEWS & PERSPECTIVES
- Inflammation in neurodegenerative diseases
- (2010) Sandra Amor et al. IMMUNOLOGY
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic-Ischemic Brain Injury
- (2010) V. S. Ten et al. JOURNAL OF NEUROSCIENCE
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study
- (2010) Tanya Simuni et al. MOVEMENT DISORDERS
- Statins in traumatic brain injury
- (2010) Elissa F. Wible et al. Neurotherapeutics
- Minocycline to Improve Neurologic Outcome in Stroke (MINOS)
- (2010) Susan C. Fagan et al. STROKE
- The Complement Inhibitor FUT-175 Suppresses T Cell Autoreactivity in Experimental Autoimmune Encephalomyelitis
- (2009) Qing Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Management of acute exacerbations in multiple sclerosis
- (2009) AlexD Rae-Grant et al. Annals of Indian Academy of Neurology
- L-type calcium channel blockers and Parkinson's disease in Denmark
- (2009) Beate Ritz et al. ANNALS OF NEUROLOGY
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
- Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage
- (2009) Matthew C. Garrett et al. BRAIN RESEARCH
- C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice*
- (2009) Luca Longhi et al. CRITICAL CARE MEDICINE
- Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis
- (2009) Markus Kipp et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- (2009) Dag Aarsland et al. LANCET NEUROLOGY
- Randomized controlled trial of memantine in dementia associated with Parkinson's disease
- (2009) Iracema Leroi et al. MOVEMENT DISORDERS
- Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
- (2009) LM Metz et al. Multiple Sclerosis Journal
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS
- (2009) J. A. Cohen et al. NEUROLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Green Tea Epigallocatechin 3-Gallate Accumulates in Mitochondria and Displays a Selective Antiapoptotic Effect Against Inducers of Mitochondrial Oxidative Stress in Neurons
- (2008) Emily K. Schroeder et al. ANTIOXIDANTS & REDOX SIGNALING
- Unique challenges in clinical trials in traumatic brain injury
- (2008) David K. Menon CRITICAL CARE MEDICINE
- Progress in neuroprotection in Parkinson’s disease
- (2008) A. H. V. Schapira EUROPEAN JOURNAL OF NEUROLOGY
- Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
- (2008) Mahmoud M. Iravani et al. EXPERIMENTAL NEUROLOGY
- Vitamin D and multiple sclerosis
- (2008) Anita Raghuwanshi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Glutathione: Overview of its protective roles, measurement, and biosynthesis
- (2008) Henry Jay Forman et al. MOLECULAR ASPECTS OF MEDICINE
- Postsynaptic mechanisms of excitotoxicity: Involvement of postsynaptic density proteins, radicals, and oxidant molecules
- (2008) J.P. Forder et al. NEUROSCIENCE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of PSD95 Inhibitors in Permanent and Transient Focal Ischemia in the Rat
- (2008) Hong-Shuo Sun et al. STROKE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now